Antidote is a digital health company focused on accelerating and improving medical research. By combining proprietary technologies, data, and well-established business models, the company is transforming the way patients and researchers connect so that breakthroughs happen faster. Antidote was launched as TrialReach in 2010 and rebranded to Antidote in 2016. The company is based in the US and the UK.
Technology: Biotechnology, Health Care, Health Diagnostics, Medical, Pharmaceutical
Industry: Data Processing, Clinical Development
Headquarters: London, England, United Kingdom
Founded Date: 2010-01-01
Employees Number: 51-100
Investors Number: 5
Total Funding: 52100000
Estimated Revenue: Less than $1M
Last Funding Date: 2021-06-03
Last Funding Type: Venture - Series Unknown

Visit Website
Register and Claim Ownership